Henri Huttunen

Henri Huttunen

Company: Herantis Pharma Plc

Job title: Chief Scientific Officer

Seminars:

HER-096: Novel Brain-Penetrating Peptidomimetic that Promotes Proteostasis & Reduces Neuroinflammation in Aged Mouse Model of Synucleinopathy 11:45 am

Discovery and lead optimization of HER-096 Blood-brain barrier penetration in small and large animals Target engagement, neuroprotection and modulation of neuroinflammation in an alpha-synuclein mouse modelRead more

day: Day Two Track A AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.